Home › Trial NCT07537738
Leukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid Leukemia
- Trial IDNCT07537738
- StatusRecruiting
- PhaseN/A
- Study typeObservational
- SponsorPeking University People's Hospital
- Enrollment210
- Start date2025-06-01
- ConditionsAcute Myeloid Leukemia (AML) · MLL Rearrangement
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.